InnovHeart

InnovHeart s.r.l., with branches in Milan, Italy, and Poway, California, USA, is developing a transcatheter mitral valve replacement (TMVR) system to treat patients with mitral valve disease. The company is currently in the preclinical development phase of its novel TMVR Saturn prosthesis, a design intended to align with the anatomical structure of the mitral valve, with both transapical and transfemoral systems under development. The company’s mission is to provide patients with an innovative treatment system suitable for replacing poorly functioning mitral valves, based on safe, effective, and user-friendly transcatheter technology.